These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19690024)

  • 1. 123I-5-IA-85380 SPECT imaging of nicotinic receptors in Alzheimer disease and mild cognitive impairment.
    Mitsis EM; Reech KM; Bois F; Tamagnan GD; Macavoy MG; Seibyl JP; Staley JK; van Dyck CH
    J Nucl Med; 2009 Sep; 50(9):1455-63. PubMed ID: 19690024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibility.
    Staley JK; van Dyck CH; Weinzimmer D; Brenner E; Baldwin RM; Tamagnan GD; Riccardi P; Mitsis E; Seibyl JP
    J Nucl Med; 2005 Sep; 46(9):1466-72. PubMed ID: 16157529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 123I-5-IA-85380 SPECT imaging of nicotinic acetylcholine receptor availability in nonsmokers: effects of sex and menstrual phase.
    Cosgrove KP; Mitsis EM; Bois F; Frohlich E; Tamagnan GD; Krantzler E; Perry E; Maciejewski PK; Epperson CN; Allen S; O'malley S; Mazure CM; Seibyl JP; van Dyck CH; Staley JK
    J Nucl Med; 2007 Oct; 48(10):1633-40. PubMed ID: 17873128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related decline in nicotinic receptor availability with [(123)I]5-IA-85380 SPECT.
    Mitsis EM; Cosgrove KP; Staley JK; Bois F; Frohlich EB; Tamagnan GD; Estok KM; Seibyl JP; van Dyck CH
    Neurobiol Aging; 2009 Sep; 30(9):1490-7. PubMed ID: 18242781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive evaluation of nicotinic acetylcholine receptor availability in mouse brain using single-photon emission computed tomography with [(123)I]5IA.
    Matsuura Y; Ueda M; Higaki Y; Watanabe K; Habara S; Kamino S; Saji H; Enomoto S
    Nucl Med Biol; 2016 Jun; 43(6):372-8. PubMed ID: 27260778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT.
    Mamede M; Ishizu K; Ueda M; Mukai T; Iida Y; Fukuyama H; Saga T; Saji H
    J Nucl Med; 2004 Sep; 45(9):1458-70. PubMed ID: 15347712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of nicotinic acetylcholine receptors in human brain using [123I]5-I-A-85380 SPET.
    Fujita M; Ichise M; van Dyck CH; Zoghbi SS; Tamagnan G; Mukhin AG; Bozkurt A; Seneca N; Tipre D; DeNucci CC; Iida H; Vaupel DB; Horti AG; Koren AO; Kimes AS; London ED; Seibyl JP; Baldwin RM; Innis RB
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1620-9. PubMed ID: 14523584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [123I]5-IA-85380 SPECT imaging of beta2-nicotinic acetylcholine receptor availability in the aging human brain.
    Mitsis EM; Cosgrove KP; Staley JK; Frohlich EB; Bois F; Tamagnan GD; Estok KM; Seibyl JP; Van Dyck CH
    Ann N Y Acad Sci; 2007 Feb; 1097():168-70. PubMed ID: 17413019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2-[(18)F]fluoro-A-85380.
    Ellis JR; Nathan PJ; Villemagne VL; Mulligan RS; Ellis KA; Tochon-Danguy HJ; Chan JG; O'keefe GJ; Bradley J; Savage G; Rowe CC
    Synapse; 2009 Sep; 63(9):752-63. PubMed ID: 19484724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of radioiodinated 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine as a ligand for SPECT investigations of brain nicotinic acetylcholine receptors.
    Saji H; Ogawa M; Ueda M; Iida Y; Magata Y; Tominaga A; Kawashima H; Kitamura Y; Nakagawa M; Kiyono Y; Mukai T
    Ann Nucl Med; 2002 May; 16(3):189-200. PubMed ID: 12126044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
    Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of alpha4beta2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECT.
    Fujita M; Tamagnan G; Zoghbi SS; Al-Tikriti MS; Baldwin RM; Seibyl JP; Innis RB
    J Nucl Med; 2000 Sep; 41(9):1552-60. PubMed ID: 10994738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioligand imaging of α4β2* nicotinic acetylcholine receptors in Alzheimer's disease and Parkinson's disease.
    Meyer PM; Tiepolt S; Barthel H; Hesse S; Sabri O
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):376-86. PubMed ID: 25387119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography.
    Kendziorra K; Wolf H; Meyer PM; Barthel H; Hesse S; Becker GA; Luthardt J; Schildan A; Patt M; Sorger D; Seese A; Gertz HJ; Sabri O
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):515-25. PubMed ID: 21069319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers.
    Cosgrove KP; Esterlis I; McKee SA; Bois F; Seibyl JP; Mazure CM; Krishnan-Sarin S; Staley JK; Picciotto MR; O'Malley SS
    Arch Gen Psychiatry; 2012 Apr; 69(4):418-27. PubMed ID: 22474108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET study.
    Ellis JR; Villemagne VL; Nathan PJ; Mulligan RS; Gong SJ; Chan JG; Sachinidis J; O'Keefe GJ; Pathmaraj K; Wesnes KA; Savage G; Rowe CC
    Neurobiol Learn Mem; 2008 Sep; 90(2):404-12. PubMed ID: 18620875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-[123I]Iodo-A-85380: assessment of pharmacological safety, radiation dosimetry and SPECT imaging of brain nicotinic receptors in healthy human subjects.
    Ueda M; Iida Y; Mukai T; Mamede M; Ishizu K; Ogawa M; Magata Y; Konishi J; Saji H
    Ann Nucl Med; 2004 Jun; 18(4):337-44. PubMed ID: 15359928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET.
    Ellis JR; Nathan PJ; Villemagne VL; Mulligan RS; Saunder T; Young K; Smith CL; Welch J; Woodward M; Wesnes KA; Savage G; Rowe CC
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):79-91. PubMed ID: 18949462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of smoking-induced occupancy of beta2-nicotinic acetylcholine receptors: estimation of nondisplaceable binding.
    Esterlis I; Cosgrove KP; Batis JC; Bois F; Stiklus SM; Perkins E; Seibyl JP; Carson RE; Staley JK
    J Nucl Med; 2010 Aug; 51(8):1226-33. PubMed ID: 20660383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
    Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
    Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.